insights_auto
Why is 4AB up 3,29%?
Dive Deeperchevron_right
4AB:ETR
AbbVie Common Stock
244,60 €
arrow_upward
+3,29%(+7,80) 1D
7 қаз., 17:35:41 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4AB...
Open
238,20 €
High
244,60 €
Low
238,00 €
Mkt. cap
484,72 млрд
Avg. vol.
672,00
Volume
348,00
52-wk high
244,60 €
52-wk low
162,85 €
No. of employees
57 мың
Open
238,20 €
High
244,60 €
Low
238,00 €
Mkt. cap
484,72 млрд
Avg. vol.
672,00
Volume
348,00
52-wk high
244,60 €
52-wk low
162,85 €
No. of employees
57 мың
News stories
From web sources and news partners
Investing News Network
·
55 минут бұрын
AbbVie's Telisotuzumab Adizutecan Receives Two Breakthrough Therapy Designations From the U.S. FDA for CRC and NSCLC
AD HOC NEWS
·
1 сағат бұрын
AbbVie stock gains 2.25 percent before October earnings date
Yahoo Finance UK
·
2 сағат бұрын
Will Linzess Continue to Aid Ironwood's Top-Line Growth in Q3?
Investing.com
·
2 сағат бұрын
AbbVie stock hits all-time high at 269.85 USD
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57 мың
Founded2012 ж. 10 сәу.
HeadquartersNorth Chicago, Иллинойс, Америка Құрама Штаттары
Sector-
Websiteabbvie.com